Jack L. Erion

6.3k total citations
42 papers, 2.6k citations indexed

About

Jack L. Erion is a scholar working on Epidemiology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jack L. Erion has authored 42 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Epidemiology, 19 papers in Oncology and 17 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jack L. Erion's work include Neuroendocrine Tumor Research Advances (23 papers), Radiopharmaceutical Chemistry and Applications (17 papers) and Lung Cancer Research Studies (11 papers). Jack L. Erion is often cited by papers focused on Neuroendocrine Tumor Research Advances (23 papers), Radiopharmaceutical Chemistry and Applications (17 papers) and Lung Cancer Research Studies (11 papers). Jack L. Erion collaborates with scholars based in United States, Netherlands and Switzerland. Jack L. Erion's co-authors include Marion de Jong, Eric P. Krenning, Michelle Schmidt, Willem H. Bakker, Ananth Srinivasan, Dik J. Kwekkeboom, P.P.M. Kooij, A. Srinivasan, Joseph E. Bugaj and Wouter A.P. Breeman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLANT PHYSIOLOGY.

In The Last Decade

Jack L. Erion

42 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jack L. Erion United States 26 1.4k 1.3k 1.3k 687 415 42 2.6k
Jean‐Claude Schaer Switzerland 21 1.6k 1.1× 1.3k 1.0× 716 0.6× 708 1.0× 662 1.6× 39 2.7k
Tina Binderup Denmark 26 962 0.7× 1.0k 0.8× 599 0.5× 710 1.0× 473 1.1× 61 2.4k
Θεοδοσία Μάινα Greece 32 1.4k 0.9× 2.0k 1.5× 2.1k 1.6× 194 0.3× 560 1.3× 127 3.3k
Sylvie Froidevaux Switzerland 15 435 0.3× 550 0.4× 794 0.6× 177 0.3× 414 1.0× 38 1.4k
Julie Nonnekens Netherlands 21 328 0.2× 490 0.4× 514 0.4× 183 0.3× 390 0.9× 51 1.2k
Rosalba Mansi Switzerland 26 813 0.6× 1.2k 0.9× 1.3k 1.0× 155 0.2× 428 1.0× 59 2.1k
Berthold A. Nock Greece 30 1.2k 0.8× 1.8k 1.4× 1.8k 1.4× 156 0.2× 447 1.1× 110 2.8k
Bart Cornelissen United Kingdom 29 140 0.1× 948 0.7× 1.1k 0.8× 109 0.2× 914 2.2× 112 2.5k
Jan Mařı́k United States 30 200 0.1× 671 0.5× 1.3k 1.0× 41 0.1× 1.2k 2.8× 71 2.7k
Annemarie Eek Netherlands 19 325 0.2× 501 0.4× 692 0.5× 74 0.1× 279 0.7× 28 1.2k

Countries citing papers authored by Jack L. Erion

Since Specialization
Citations

This map shows the geographic impact of Jack L. Erion's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack L. Erion with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack L. Erion more than expected).

Fields of papers citing papers by Jack L. Erion

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jack L. Erion. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack L. Erion. The network helps show where Jack L. Erion may publish in the future.

Co-authorship network of co-authors of Jack L. Erion

This figure shows the co-authorship network connecting the top 25 collaborators of Jack L. Erion. A scholar is included among the top collaborators of Jack L. Erion based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jack L. Erion. Jack L. Erion is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Delpassand, Ebrahim S., Amin Samarghandi, Sara Zamanian, et al.. (2014). Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE for Patients With Somatostatin Receptor–Expressing Neuroendocrine Tumors. Pancreas. 43(4). 518–525. 108 indexed citations
2.
Breeman, Wouter A.P., Erik de Blois, Arthur van Gameren, et al.. (2008). Optimised labeling, preclinical and initial clinical aspects of CCK-2 receptor-targeting with 3 radiolabeled peptides. Nuclear Medicine and Biology. 35(8). 839–849. 57 indexed citations
3.
Bernard, Bert F., Ananth Srinivasan, Jack L. Erion, et al.. (2007). Five Stabilized 111 In-Labeled Neurotensin Analogs in Nude Mice Bearing HT29 Tumors. Cancer Biotherapy and Radiopharmaceuticals. 22(3). 374–382. 4 indexed citations
4.
Norenberg, Jeffrey P., Tamara L. Anderson, Jack L. Erion, et al.. (2006). Characterization of a Radiolabeled Small Molecule Targeting Leukocyte Function–Associated Antigen-1 Expression in Lymphoma and Leukemia. Cancer Biotherapy and Radiopharmaceuticals. 21(5). 418–426. 5 indexed citations
5.
Capello, Astrid, Eric P. Krenning, Bert F. Bernard, et al.. (2006). Anticancer activity of targeted proapoptotic peptides.. PubMed. 47(1). 122–9. 49 indexed citations
6.
Bernard, Bert F., Astrid Capello, Martin van Hagen, et al.. (2004). Radiolabeled RGD-DTPA-Tyr 3 -Octreotate for Receptor-Targeted Radionuclide Therapy. Cancer Biotherapy and Radiopharmaceuticals. 19(2). 173–180. 29 indexed citations
7.
Breeman, Wouter A.P., Marion de Jong, Theo J. Visser, Jack L. Erion, & Eric P. Krenning. (2003). Optimising conditions for radiolabelling of DOTA-peptides with 90Y, 111In and 177Lu at high specific activities. European Journal of Nuclear Medicine and Molecular Imaging. 30(6). 917–920. 173 indexed citations
8.
Visser, M., A. Srinivasan, Jean Claude Reubi, et al.. (2003). Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer. European Journal of Nuclear Medicine and Molecular Imaging. 30(8). 1134–1139. 78 indexed citations
9.
Breeman, Wouter A.P., Bert F. Bernard, Arthur van Gameren, et al.. (2003). The addition of DTPA to [177Lu-DOTA0,Tyr3]octreotate prior to administration reduces rat skeleton uptake of radioactivity. European Journal of Nuclear Medicine and Molecular Imaging. 30(2). 312–315. 63 indexed citations
10.
Lewis, Jason S., Mu Wang, Richard Laforest, et al.. (2001). Toxicity and dosimetry of177Lu-DOTA-Y3-octreotate in a rat model. International Journal of Cancer. 94(6). 873–877. 51 indexed citations
11.
Kwekkeboom, Dik J., Willem H. Bakker, P.P.M. Kooij, et al.. (2001). [177Lu-DOTA0,Tyr3]octreotate: comparison with [111In-DTPA0]octreotide in patients. European Journal of Nuclear Medicine and Molecular Imaging. 28(9). 1319–1325. 368 indexed citations
12.
Bugaj, Joseph E., Jack L. Erion, Michael A. Johnson, Michelle Schmidt, & Ananth Srinivasan. (2001). Radiotherapeutic efficacy of 153Sm-CMDTPA-Tyr3-octreotate in tumor-bearing rats☆. Nuclear Medicine and Biology. 28(3). 327–334. 21 indexed citations
13.
Jong, Marion de, Wout A. P. Breeman, Willem H. Bakker, et al.. (2001). [177Lu-DOTA0,Tyr3]octreotate for somatostatin receptor-targeted radionuclide therapy. International Journal of Cancer. 92(5). 628–633. 172 indexed citations
14.
Kwekkeboom, Dik J., Willem H. Bakker, P.P.M. Kooij, et al.. (2000). Cholecystokinin receptor imaging using an octapeptide DTPA-CCK analogue in patients with medullary thyroid carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. 27(9). 1312–1317. 69 indexed citations
15.
Reubi, Jean Claude, Beatrice Waser, Jean‐Claude Schaer, et al.. (1998). Unsulfated DTPA- and DOTA-CCK analogs as specific high-affinity ligands for CCK-B receptor-expressing human and rat tissues in vitro and in vivo. European Journal of Nuclear Medicine and Molecular Imaging. 25(5). 481–490. 71 indexed citations
16.
Erion, Jack L., et al.. (1991). Isolation and Characterization of a Tomato Acid Phosphatase Complementary DNA Associated with Nematode Resistance. PLANT PHYSIOLOGY. 97(4). 1462–1469. 7 indexed citations
17.
Erion, Jack L.. (1985). Characterization of the mRNA transcripts of the maize, ribulose-1,5-bisphosphate carboxylase, large subunit gene. Plant Molecular Biology. 4(2-3). 169–179. 22 indexed citations
18.
Erion, Jack L., et al.. (1983). Synthesis of the large subunit of ribulose-1,5-bisphosphate carboxylase in anin vitro partially definedE. coli system. Plant Molecular Biology. 2(5). 279–290. 15 indexed citations
19.
Erion, Jack L. & Joan E.B. Fox. (1981). Purification and Properties of a Protein Which Binds Cytokinin-active 6-Substituted Purines. PLANT PHYSIOLOGY. 67(1). 156–162. 29 indexed citations
20.
Erion, Jack L., et al.. (1980). Euglena gracilis chloroplast EF-Ts. Evidence that it is a nuclear-coded gene product.. Journal of Biological Chemistry. 255(13). 6018–6019. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Claude Schaer Breakdown of academic impact, for papers by Tina Binderup Breakdown of academic impact, for papers by Θεοδοσία Μάινα Breakdown of academic impact, for papers by Sylvie Froidevaux Breakdown of academic impact, for papers by Julie Nonnekens Breakdown of academic impact, for papers by Rosalba Mansi Breakdown of academic impact, for papers by Berthold A. Nock Breakdown of academic impact, for papers by Bart Cornelissen Breakdown of academic impact, for papers by Jan Mařı́k Breakdown of academic impact, for papers by Annemarie Eek
Rankless by CCL
2026